Sulfadiazine

Sulfadiazine

250px
250px
Systematic (IUPAC) name
4-amino-N-pyrimidin- 2-yl-benzenesulfonamide
Clinical data
Pregnancy category	?
Routes of administration	Cream
Legal status
Legal status	Approved Drug
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Biological half-life	?
Excretion	?
Identifiers
CAS Number	68-35-9
ATC code	J01EC02 (WHO) QJ01EQ10
PubChem	CID 5215
DrugBank	APRD00190
Chemical data
Formula	C10H10N4O2S
Molar mass	250.278 g/mol[[]]
(verify)

Sulfadiazine is a sulfonamide antibiotic.

Uses

It eliminates bacteria that cause infections by stopping the production of folic acid inside the bacterial cell, and is commonly used to treat urinary tract infections (UTIs).

In combination, sulfadiazine and pyrimethamine, can be used to treat toxoplasmosis, a disease caused by Toxoplasma gondii.

Side effects

Side effects reported for sulfadiazine include: nausea, upset stomach, loss of appetite, and dizziness.

Brand names

Lantrisul; Neotrizine; Sulfa-Triple #2; Sulfadiazine; Sulfaloid; Sulfonamides Duplex; Sulfose; Terfonyl; Triple Sulfa; Triple Sulfas; Triple Sulfoid

See also

• Silver sulfadiazine

External links

• Sulfadiazine (patient information)

es:Sulfadiazina